CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Hosted on MSN9d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
Irish Examiner on MSN3d
Nasal irrigation: Breathe easy by flushing out your nasal cavityNasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
Inquirer on MSN5d
World’s first anti-depression nasal spray receives FDA approvalThe US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
Prevention on MSN9d
7 Ways to Stop Post-Nasal Drip, According to DoctorsAnother natural method that may help you find relief from environmental factors behind your post-nasal drip is by inhaling ...
Nandita Vijayasimha, Bengaluru Thursday, February 6, 2025, 08:00 Hrs [IST] ...
The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
The NDA is supported by data from a clinical trial that compared the absorption and efficacy of the nasal treatment with oral and IV bumetanide in 68 healthy adults.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback